MannKind Corporation (MNKD)
NASDAQ·Healthcare·Biotechnology
$3.66
-1.81%
Mkt Cap $1.13B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$8.25
Range $6.00 – $10.00
Implied Upside
+125.4%
Consensus $8.25 vs current $3.66
NASDAQ·Healthcare·Biotechnology
$3.66
-1.81%
Mkt Cap $1.13B
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$8.25
Range $6.00 – $10.00
+125.4%
Consensus $8.25 vs current $3.66